- Directorate-General for Health and Food Safety [DG SANTE] (2019). PHARM 788. Note to the Pharmaceutical Committee updating on the actions undertaken with regard to the quality of Active Pharmaceutical Ingredients (API). Pharmaceutical Committee meeting on 7 November 2019.
https://ec.europa.eu/health/sites/health/files/files/committee/ev_20191217_788_en.pdf - Directorate-General for Health and Food Safety [DG SANTE] (2020). PHARM 795.
PHARMACEUTICAL COMMITTEE on 12 March 2020. Dependency of the EU pharmaceutical industry on active pharmaceutical ingredients and chemical raw materials imported from third countries.
https://ec.europa.eu/health/sites/health/files/files/committee/ev_20200312_795_en.pdf - Directorate-General for Trade [DG TRADE] (2020). European Union, Trade in goods with China.
https://webgate.ec.europa.eu/isdb_results/factsheets/country/details_china_en.pdf - Duxbury, C. (2020). Europe’s last free-traders plan their counterattack.
https://www.politico.eu/article/europes-last-free-traders-plan-their-counter-attack/
- EFPIA, AESGP, EAHP, EAEPC, EIPG, GIRP, Medicines for Europe, and PGEU ('Supply chain actors') (2019). Position Paper: Addressing the root causes of medicines shortages: Supply chain Stakeholders’ views on root causes and solutions. 6 December 2019.
https://www.efpia.eu/media/413378/addressing-the-root-causes-of-medicines-shortages-final-051219.pdf
- EFPIA, AESGP, EAHP, EAEPC, EIPG, GIRP, Medicines for Europe, and PGEU ('Supply chain actors') (2017). Joint Supply Chain Actors Statement on Information and Medicinal Products Shortages.
https://www.efpia.eu/media/25913/joint_supply_chain_actors_statement_on_information_a nd_medicinal_products_shortages.pdf
- EFPIA, AESGP, EAHP, EAEPC, EIPG, GIRP, Medicines for Europe, and PGEU ('Supply chain actors') (2018). Supply chain commitment to tackling problem of medicine shortages.
https://eipg.eu/wp-content/uploads/2018/03/supply-chain-stakeholders-commitment-to-medicine-shortages.pdf
- Elbe, S. (2006). Should HIV/AIDS Be Securitized? The Ethical Dilemmas of Linking HIV/AIDS and Security. International Studies Quarterly. Mar. 2006. Vol. 50. No. 1, pp. 119-144.
- EPHA, Active Citizenship Network, Collectif Interassociatif Sur la Santé (CISS), Doctors of the World, European AIDS Treatment Group (EATG), Health Action International – Europe (HAI Europe), Salud por Derecho - Right to Health Foundation, Trans Atlantic Consumer Dialogue (TACD) (2013). Joint declaration on access to medicines: ringing alarm bells on a deepening problem. https://epha.org/press-release-joint-declaration-on-access-to-medicines-ringing-alarm-bells-on-a-deepening-problem/
- EPHA, AEMH, AGE Platform Europe, AIM, BEUC, The Council of European Dentists, Corporate Europe Observatory, Standing Committee of European Doctors, The European AIDS Treatment Group, European Association of Hospital Pharmacists, Association of European Cancer
Leagues, The European Federation of Allergy and Airways Diseases Patients’ Associations, European Forum for Primary Care, European Health Management Association, European Heart Network, European Institute of Women’s Health, ELPA, EMSA, European Patients’
Forum, EPHA, ESIP, European Public Health Association, Health Action International, Health Care Without Harm Europe, Health and Environment Alliance, HOPE, International Diabetes Federation, IFMSA, The International Society of Drug Bulletins, Medicines in Europe Forum,
Nordic Cochrane Centre, PGEU, SFP, UAEM, European Union of Medical Specialist. (2014).
Open Letter to President-elect Jean-Claude Juncker on move of medicinal products and health technologies to the portfolio of the Commissioner for internal market and industry.
https://noharm-europe.org/documents/open-letter-president-elect-jean-claude-juncker-move-medicinal-products
- EPHA, AFA – Crohn RCH France, EFCCA– European Federation of Crohns & Ulcerative, AFH – Association française des hémophiles Colitis Association, AGE Platform Europe, EHC – European Haemophilia Consortium, AIDES, EIWH – European Institute of Women’s Health, Altroconsumo, EKPIZO-Consumers’Association “The Quality of Life, Amalyste, APAA – Autoimmune Diseases Patient Association Romania, Épilepsie France, ARAS – Asociatia Romana Anti-Sida, France Assos Santé, ASPLA – Asociatia Prietenii lui Adrian, France
Lymphome Espoir, BAPD – Bulgarian Association for Patients’ Defense, Give Life Foundation, CHV – Collectif Hépatites Virales, HAI – Health Action International, DECO PROTESTE, OCU – Organización de Consumidores y Usuarios, EAHP – European Association of Hospital
Pharmacists, ORS – Romanian Health Observatory, EAP – European Academy of Paediatrics, Prescrire, EATG – European AIDS Treatment Group, Test Achats. ECL Access to Medicines Task Force, TRT-5 (2019). EPHA joins calls for investigation into EU medicines shortages.
https://epha.org/epha-joins-calls-for-investigation-into-eu-medicines-shortages/
- EPHA, AFH, EHC, AFSA, AFTOC, Troubles Obsessionnels et Compulsifs, Épilepsie-France, France Assos Santé, AGE Platform Europe, France Lymphome Espoir, AIDES, France Parkinson, AIM, Give Life Foundation, Altroconsumo, HAI, APAA, La Ligue contre le cancer, ARAS, La LUSS, ASPLA, Le Lien, BEUC, OCU, CLVC, ORS, Prescrire, DECO PROTESTE, Renaloo, EAHP, SOS-Hépatites, EAP, Test Achats, EATG, TRT-5, CHV, ECCO, UFC-Que Choisir, ECL Access to Medicines Task Force, EFAPPE, UNAPECLE, Vlaams Patiëntenplatform, EFCCA, Colitis Association (2019a). Proposal of public hearing and own initiative report on medicines shortages in the EU.
https://www.eahp.eu/sites/default/files/medicines_shortages_letter_mep_canfin.pdf - Euractiv.com (2009). NGOs want medicines removed from EU industry policy.
https://www.euractiv.com/section/science-policymaking/news/ngos-want-medicines-removed-from-eu-industry-policy/
- Euractiv.com (2014). Report: Patients suffer from medicine shortages throughout EU.
https://www.euractiv.com/section/health-consumers/news/report-patients-suffer-from-medicine-shortages-throughout-eu/
- Euractiv.com (2020). Politics aside, US relies on China supplies to fight virus.
https://www.euractiv.com/section/china/news/politics-aside-us-relies-on-china-supplies-to-fight-virus/
- European Association of Hospital Pharmacists [EAHP] (2013). European pharmacist
organisations make joint call for action on medicines shortages. https://www.eahp.eu/press-room/european-pharmacist-organisations-make-joint-call-action-medicines-shortages - European Association of Hospital Pharmacists [EAHP] (2014). Patients suffering from
medicines shortages in all European countries. https://www.eahp.eu/press-room/patients-suffering-medicines-shortages-all-european-countries
- European Association of Hospital Pharmacists [EAHP] (2018). 2018 EAHP survey results – the medicines shortages problem continues to persist. https://www.eahp.eu/press-room/2018-eahp-survey-results-%E2%80%93-medicines-shortages-problem-continues-persist
- European Association of Hospital Pharmacists [EAHP] (2020). EAHP’s 2019 Medicines Shortages Report – the problem continues to grow.
https://www.eahp.eu/press- room/eahp%E2%80%99s-2019-medicines-shortages-report-%E2%80%93-problem-continues-grow
- https://ec.europa.eu/commission/presscorner/detail/en/speech_10_188
- European Commission [EC] (2003). COM(2003) 383 final: A Stronger European-based Pharmaceutical Industry for the Benefit of the Patient – A Call for Action. 1 July 2003.
https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2003:0383:FIN:EN:PDF
- European Commission [EC] (2005). COM(2005) 474 final: Implementing the Community Lisbon Programme: A policy framework to strengthen EU manufacturing - towards amore integrated approach for industrial policy.
https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2005:0474:FIN:en:PDF
- European Commission [EC] (2006). Commissioner Kyprianou visits China to discuss avian flu, influenza preparedness and product safety.
https://ec.europa.eu/commission/presscorner/detail/en/ip_06_44
- European Commission [EC] (2008). SEC(2008) 2674: COMMISSION STAFF WORKING DOCUMENT Accompanying document to the Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Directive 2001/83/EC as regards the
prevention of the entry into the legal supply chain of medicinal products which are falsified in relation to their identity, history or source. Impact Assessment. Brussels, 10.12.2008.
https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52008SC2674&from=EN - European Commission [EC] (2008a). COM(2008) 666 final: Safe, Innovative and Accessible
Medicines: a Renewed Vision for the Pharmaceutical Sector. 10 December 2008.
("Pharmaceutical Package")
https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2008:0666:FIN:en:PDF
- European Commission [EC] (2010). Keynote speech by John Dalli, Member of the European Commission, responsible for Health and Consumer Policy at the Transatlantic Consumer Dialogue (TACD) Conference in Washington Washington, USA. 27 April 2010.
https://ec.europa.eu/commission/presscorner/detail/en/speech_10_188
- European Commission [EC] (2010a). COM(2010) 614 final: An Integrated Industrial Policy for the Globalisation Era Putting Competitiveness and Sustainability at Centre Stage. https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2010:0614:FIN:EN:PDF
- European Commission [EC] (2012). COM(2012) 582 final: A Stronger European Industry for Growth and Economic Recovery.
https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A52012DC0582
- European Commission [EC] (2014). COM(2014) 14 final: For a European Industrial
Renaissance. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52014DC0014 - European Commission [EC] (2017). COM(2017) 479 final: Investing in a smart, innovative and
sustainable Industry - A renewed EU Industrial Policy Strategy. http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=COM:2017:479:FIN
- European Commission [EC] (2018). Paper on the obligation of continuous supply to tackle the problem of shortages of medicines - Agreed by the Ad-hoc technical meeting under the Pharmaceutical Committee on shortages of medicines on 25 May 2018.
https://ec.europa.eu/health/sites/health/files/files/committee/ev_20180525_rd01_en.pdf
- European Commission [EC] (2019). Europe in May 2019: Preparing for a more united, stronger and more democratic Union in an increasingly uncertain world - Communication. The
European Commission's contribution to the informal EU27 leaders' meeting in Sibiu (Romania) on 9 May 2019. https://ec.europa.eu/commission/future-europe/commissions-contribution-informal-eu27-leaders-meeting-sibiu-romania-9-may-2019_en
- European Commission [EC] (2019a). Speech: The value of EU in healthcare - The European Federation of Pharmaceutical Industries and Associations. 27 June 2019.
https://www.vbb.com/insights/corporate-commercial-regulatory/in-parting-speech- commissioner-andriukaitis-argues-in-favour-of-medicine-access-and-against-medicine-shortages
- European Commission [EC] (2019b). President-elect of the European Commission Ursula von der Leyen's Mission letter to Commissioner-designate for Health Stella Kyriakides. Brussels, 10 September 2019. https://ec.europa.eu/commission/sites/beta-political/files/mission-letter-stella-kyriakides_en.pdf
- European Commission [EC] (2020). Trust and reciprocity: the necessary ingredients for EU-China cooperation. https://eeas.europa.eu/delegations/china/79582/trust-and-reciprocity-necessary-ingredients-eu-china-cooperation_en
- European Commission [EC] (2020a). Webpage of Commission Expert Group on Safe and Timely Access to Medicines for Patients ("STAMP").
https://ec.europa.eu/health/documents/pharmaceutical-committee/stamp_en
- European Commission [EC] (2020b). COM(2020) 102 final: A New Industrial Strategy for Europe. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52020DC0102 - European Commission [EC] (2020c). Coronavirus: Commission calls on Member States to
optimise supply and availability of medicines.
https://ec.europa.eu/commission/presscorner/detail/en/ip_20_622 - European Commission [EC] (2020d). Pharmaceutical strategy for Europe.
https://ec.europa.eu/health/human-use/strategy_en
- European Commission [EC] (2020f). European Commission kicks off major EU trade policy review. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1058
- European Commission [EC] (2020g). Speech by Commissioner Phil Hogan at Launch of Public Consultation for EU Trade Policy Review - Hosted by EUI Florence.
https://ec.europa.eu/commission/commissioners/2019-2024/hogan/announcements/speech- commissioner-phil-hogan-launch-public-consultation-eu-trade-policy-review-hosted-eui-florence_en
- European Commission [EC] (2020h). Keynote speech by President von der Leyen at the World Economic Forum. https://ec.europa.eu/commission/presscorner/detail/en/speech_20_102 - European Commission [EC] (2020i). For a united, resilient and sovereign Europe. Op-ed by
Internal Market Commissioner T. Breton and HRVP J. Borrell.
https://eeas.europa.eu/delegations/china/80787/united-resilient-and-sovereign-europe_en - European Commission [EC] (2020j). Letter to the European Pharmaceutical Industry from the
Commissioner for Health, Stella Kyriakides, on 3 April 2020. https://www.oeb.org.cy/wp- content/uploads/2020/04/Letter-from-Commissioners-Kyriakides-to-the-pharmaceutical-industries.pdf
- European Commission [EC] (2020k). COMP/OG – D(2020/044003). EU Commission, Comfort letter: coordination in the pharmaceutical industry to increase production and to improve supply of urgently needed critical hospital medicines to treat COVID-19 patients. 8 April 2020.
https://ec.europa.eu/competition/antitrust/medicines_for_europe_comfort_letter.pdf - European Commission [EC] (2020l). C(2020) 3200 final: Temporary Framework for assessing
antitrust issues related to business cooperation in response to situations of urgency stemming from the current COVID-19 outbreak. 8 April 2020.
https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52020XC0408(04)
- European Commission [EC] (2020m). C(2020) 2272: Guidelines on the optimal and rational supply of medicines to avoid shortages during the COVID-19 outbreak. 8 April 2020.
https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.CI.2020.116.01.0001.01.ENG&toc=OJ:C:2020:116I:TOC - European Commission [EC] (2020n). COM(2020) 318 final: Short-term EU health preparedness
for COVID-19 outbreaks. 15 July 2020.
https://ec.europa.eu/info/sites/info/files/communication_-_short-term_eu_health_preparedness.pdf
- European Commission [EC] (2020o). Roadmap: Pharmaceutical Strategy - Timely patient access to affordable medicines. 3 June 2020.
https://ec.europa.eu/info/law/better- regulation/have-your-say/initiatives/12421-Pharmaceutical-Strategy-Timely-patient-access-to-affordable-medicines
- European Commission [EC] (2020p). Workshop summary: Pharmaceutical Strategy for Europe.
Brussels, 14-15 July 2020. https://ec.europa.eu/health/sites/health/files/human-use/docs/stakeholders_sum_workshop_en.pdf
- European Commission [EC] (2020q). A renewed trade policy for a stronger Europe.
Consultation Note. 16 June 2020.
https://trade.ec.europa.eu/doclib/docs/2020/june/tradoc_158779.pdf
- European Federation of Pharmaceutical Industries and Associations [EFPIA] (2019). EFPIA statement on Medicine Shortages in Europe. https://www.efpia.eu/news-events/the-efpia-view/statements-press-releases/efpia-statement-on-medicine-shortages-in-europe/
- European Federation of Pharmaceutical Industries and Associations [EFPIA] (2020). Tackling COVID-19: EFPIA welcomes proactive and regular dialogue with Commissioners on the supply of medicines during the COVID-19 pandemic. https://www.efpia.eu/news-events/the-efpia- view/statements-press-releases/tackling-covid-19-efpia-welcomes-proactive-and-regular-dialogue-with-commissioners-on-the-supply-of-medicines-during-the-covid-19-pandemic/
- European Federation of Pharmaceutical Industries and Associations [EFPIA] (2020a). Europe’s COVID-19 battle: Update on the supply of medicines to the patients that need them.
https://www.efpia.eu/news-events/the-efpia-view/statements-press-releases/europe-s-covid-19-battle-update-on-the-supply-of-medicines-to-the-patients-that-need-them/
- European Federation of Pharmaceutical Industries and Associations [EFPIA] (2020b). Europe’s COVID-19 battle: Update on the supply of medicines to the patients that need them.
https://www.efpia.eu/news-events/the-efpia-view/statements-press-releases/europe-s-covid-19-battle-update-on-the-supply-of-medicines-to-the-patients-that-need-them-1/
- European Federation of Pharmaceutical Industries and Associations [EFPIA] (2020c). Europe’s COVID-19 battle: working together to ensure the supply of medicines to the patients that need them.
https://www.efpia.eu/news-events/the-efpia-view/statements-press- releases/europe-s-covid-19-battle-working-together-to-ensure-the-supply-of-medicines-to-the-patients-that-need-them/
- European Federation of Pharmaceutical Industries and Associations [EFPIA] (2020d). Europe’s COVID-19 battle: Update on the supply of medicines to the patients that need them
https://www.efpia.eu/news-events/the-efpia-view/statements-press-releases/europe-s-covid-19-battle-update-on-the-supply-of-medicines-to-the-patients-that-need-them-2/
- European Federation of Pharmaceutical Industries and Associations [EFPIA] (2020f). Europe’s COVID-19 battle: Update on the supply of medicines to the patients that need them.
https://www.efpia.eu/news-events/the-efpia-view/statements-press-releases/09042020- europe-s-covid-19-battle-update-on-the-supply-of-medicines-to-the-patients-that-need-them/
- European Federation of Pharmaceutical Industries and Associations [EFPIA] (2020h). EU strategic resilience in pharmaceuticals: global value chains and innovation.
https://www.efpia.eu/news-events/the-efpia-view/blog-articles/eu-strategic-resilience-in-pharmaceuticals-global-value-chains-and-innovation/
- European Fine Chemicals Group [EFCG] (2019). Addressing the acute and complex issue of medicines shortages. https://efcg.cefic.org/wp-content/uploads/2019/10/2019-Sept-EFCG-pharma-raw-material-shortages.pdf
- European Fine Chemicals Group [EFCG] & Bulk Pharmaceuticals Task Force [BPTF] (2020).
Press release: Active Pharmaceutical Ingredients manufacturers address critical medicines shortages leaving Europeans and Americans vulnerable and dependent on Asian supplies.
https://efcg.cefic.org/mediaroom/press-release-api-manufacturers-address-critical- medicines-shortages-leaving-europeans-and-americans-vulnerable-and-dependent-on-asian-supplies/
- European Medicines Agency [EMA] (2012). EMA/590745/2012. Reflection paper on medicinal product supply shortages caused by manufacturing/Good Manufacturing Practice Compliance problems. https://www.lif.se/contentassets/2a789e9b7fec42c1b50284e5942b3201/ema-om-restnoterade-lakemedel.pdf
- European Medicines Agency [EMA] (2018). EU regulatory network reflection paper on the availability of authorised medicinal products for human and veterinary use.
https://www.ema.europa.eu/en/documents/other/eu-regulatory-network-reflection-paper-availability-authorised-medicinal-products-human-veterinary_en.pdf
- European Medicines Agency [EMA] (2019). EMA/674304/2018. Guidance on detection and notification of shortages of medicinal products for Marketing Authorisation Holders (MAHs) in the Union (EEA).
https://www.ema.europa.eu/en/human-regulatory/post-authorisation/availability-medicines
- European Medicines Agency [EMA] (2018a). HMA/EMA workshop on availability of authorised medicines - Report from a multi-stakeholder meeting held at EMA on 9th November 2018.
https://www.ema.europa.eu/en/human-regulatory/post-authorisation/availability-medicines - European Medicines Agency [EMA] (2019a). EMA/632473/2018. Good practice guidance for
communication to the public on medicines’ availability issues.
https://www.ema.europa.eu/en/human-regulatory/post-authorisation/availability-medicines - European Parliament [EP] (2012). Parliamentary questions E-010761-12. Question for written
answer to the Commission Rule 117 by Thomas Ulmer (PPE) on 27 November 2012
https://www.europarl.europa.eu/sides/getDoc.do?pubRef=-//EP//TEXT+WQ+E-2012-010761+0+DOC+XML+V0//EN&language=EN
- European Parliament [EP] (2011). Parliamentary questions E-011583/2011. Question for written answer to the Commission Rule 117 by Thomas Ulmer (PPE) on 8 December 2011.
https://www.europarl.europa.eu/sides/getDoc.do?type=WQ&reference=E-2011-011583&language=PL
- European Parliament [EP] (2012a). Parliamentary questions P-009858-12: Question for written answer to the Commission Rule 117 by Françoise Grossetête (PPE) on Question for written answer to the Commission Rule 117 by Françoise Grossetête (PPE) on 29 October 2012.
https://www.europarl.europa.eu/sides/getDoc.do?type=WQ&reference=P-2012-009858&language=EN
- European Parliament [EP] (2012b). Parliamentary questions E-011443-12: Question for written answer to the Commission Rule 117 by Anna Rosbach (ECR) on 17 December 2012.
https://www.europarl.europa.eu/sides/getDoc.do?pubRef=-//EP//TEXT+WQ+E-2012-011443+0+DOC+XML+V0//EN&language=EN
- European Parliament [EP] (2013). Parliamentary questions E-000466-13: Question for written answer to the Commission Rule 117 by Esther de Lange (PPE) on 17 January 2013.
https://www.europarl.europa.eu/sides/getDoc.do?pubRef=-//EP//TEXT+WQ+E-2013-000466+0+DOC+XML+V0//EN&language=EN
- European Parliament [EP] (2013a). Parliamentary questions E-012995-13: Question for written answer to the Commission Rule 117 by Christine De Veyrac (PPE) on 15 November 2013.
https://www.europarl.europa.eu/sides/getDoc.do?pubRef=-//EP//TEXT+WQ+E-2013-012995+0+DOC+XML+V0//EN&language=EN
- European Parliament [EP] (2014). Parliamentary questions E-007032-14: Question for written answer to the Commission Rule 130 by Sergio Gutiérrez Prieto (S&D) on 22 September 2014.
https://www.europarl.europa.eu/doceo/document/E-8-2014-007032_EN.html
- European Parliament [EP] (2014a). Parliamentary questions E-007085-14: Question for written answer to the Commission Rule 130 by Marc Tarabella (S&D) on 23 September 2014.
https://www.europarl.europa.eu/doceo/document/E-8-2014-007085_EN.html - European Parliament [EP] (2014b). Parliamentary questions E-009450-14: Question for
written answer to the Commission Rule 130 by Claudiu Ciprian Tănăsescu (S&D) on 19 November 2014. https://www.europarl.europa.eu/doceo/document/E-8-2014-009450_EN.html
- European Parliament [EP] (2014c). Parliamentary questions E-009775-14: Question for written answer to the Commission Rule 130 by Marlene Mizzi (S&D) on 26 November 2014.
https://www.europarl.europa.eu/doceo/document/E-8-2014-009775_EN.html
- European Parliament [EP] (2015). Parliamentary questions E-005047/2015: Question for written answer to the Commission Rule 130 by Mara Bizzotto (NI) on 31 March 2015.
https://www.europarl.europa.eu/doceo/document/E-8-2015-005047_EN.html
- European Parliament [EP] (2015a). Parliamentary questions E-000971-15: Question for written answer to the Commission Rule 130 by Roberta Metsola (PPE) on 23 January 2015.
https://www.europarl.europa.eu/doceo/document/E-8-2015-000971_EN.html
- European Parliament [EP] (2016). Parliamentary questions P-002868-16: Question for written answer to the Commission Rule 130 by Kateřina Konečná (GUE/NGL) & Jiří Maštálka
(GUE/NGL) on 8 April 2016. https://www.europarl.europa.eu/doceo/document/P-8-2016-002868_EN.html
- European Parliament [EP] (2016a). Parliamentary questions E-002907-16: Question for written answer to the Commission Rule 130 by Nikolaos Chountis (GUE/NGL) on 11 April 2016.
https://www.europarl.europa.eu/doceo/document/E-8-2016-002907_EN.html
- European Parliament [EP] (2017). Parliamentary questions E-003667-17: Question for written answer to the Commission Rule 130 by Soledad Cabezón Ruiz (S&D) on 1 June 2017.
https://www.europarl.europa.eu/doceo/document/E-8-2017-003667_EN.html
- European Parliament [EP] (2018). Parliamentary questions E-000365-18: Question for written answer to the Commission Rule 130 by Cristian-Silviu Buşoi (PPE) on 24 January 2018.
https://www.europarl.europa.eu/doceo/document/E-8-2018-000365_EN.html
- European Parliament [EP] (2018a). Parliamentary questions P-001287-18: Question for written answer to the Commission Rule 130 by Andrey Kovatchev (PPE) on 1 March 2018.
https://www.europarl.europa.eu/doceo/document/P-8-2018-001287_EN.html
- European Parliament [EP] (2019). Parliamentary questions E-000315-19: Question for written answer to the Commission Rule 130 by Mireille D'Ornano (EFDD) on 23 January 2019.
https://www.europarl.europa.eu/doceo/document/E-8-2019-000315_EN.html
- European Parliament [EP] (2019a). Parliamentary questions E-001079-19: Question for written answer to the Commission Rule 130 by Soledad Cabezón Ruiz (S&D) on 27 February 2019.
https://www.europarl.europa.eu/doceo/document/E-8-2019-001079_EN.html
- European Parliament [EP] (2020). Parliamentary questions E-000211/2020. Question for written answer to the Commission Rule 138 by Bernhard Zimniok on 15 January 2020 https://www.europarl.europa.eu/doceo/document/E-9-2020-000211_EN.html
- European Parliament [EP] (2020a). A9-0142/2020: REPORT on the shortage of medicines – how to address an emerging problem (2020/2071(INI)).
https://www.europarl.europa.eu/doceo/document/A-9-2020-0142_EN.html
- European Parliament [EP] (2020b). Coronavirus outbreak, state of play and ensuring a
coordinated European response to the health, economic and social impact (debate). Tuesday, 10 March 2020 - Brussels. https://www.europarl.europa.eu/doceo/document/CRE-9-2020-03-10-ITM-004_EN.html
- European Parliament [EP] (2020c). EU coordinated action to combat the COVID-19 pandemic and its consequences (continuation of debate). Thursday, 16 April 2020 - Brussels.
https://www.europarl.europa.eu/doceo/document/CRE-9-2020-04-16-ITM-017_EN.html - European Parliament [EP] (2020d). Conclusions of the extraordinary European Council
meeting of 23 April 2020 - New MFF, own resources and Recovery plan (debate). Wednesday, 13 May 2020 - Brussels. https://www.europarl.europa.eu/doceo/document/CRE-9-2020-05-13-ITM-017_EN.html
- European Parliament [EP] (2020e). The EU’s public health strategy post-COVID-19 (debate).
Wednesday, 8 July 2020 - Brussels. https://www.europarl.europa.eu/doceo/document/CRE-9-2020-07-08-ITM-017_EN.html
- European Parliament [EP] (2020f). P9_TA(2020)0054: European Parliament resolution of 17 April 2020 on EU coordinated action to combat the COVID-19 pandemic and its consequences (2020/2616(RSP)).
https://www.europarl.europa.eu/doceo/document/TA-9-2020-0054_EN.html
- European Parliament [EP] (2020g). Coronavirus: ensuring fundamental rights and a coordinated European response (debate). Wednesday, 12 February 2020 - Strasbourg.
https://www.europarl.europa.eu/doceo/document/CRE-9-2020-02-12-ITM-026_EN.html - European Parliament [EP] (2020h). Parliamentary questions E-001604/2020. Question for
written answer to the Commission Rule 138 by Roman Haider, Markus Buchheit, Luisa
Regimenti, Maximilian Krah, Herve Juvin, Joëlle Mélin, Danilo Oscar Lancini on 13 March 2020.
https://www.europarl.europa.eu/doceo/document/E-9-2020-001604_EN.html
- European Parliament [EP] (2020i). Parliamentary questions E-001789/2020. Question for written answer to the Commission Rule 138 by Miroslav Číž on 23 March 2020.
https://www.europarl.europa.eu/doceo/document/E-9-2020-001789_EN.html
- European Parliament [EP] (2020j). "Parliamentary questions P-002156/2020. Priority question for written answer to the Commission Rule 138 by Jutta Paulus on 7 April 2020.
https://www.europarl.europa.eu/doceo/document/P-9-2020-002156_EN.html
- European Parliament [EP] (2020k). Parliamentary questions E-001897/2020. Question for written answer to the Commission Rule 138 by Roman Haider, Georg Mayer on 26 March 2020. https://www.europarl.europa.eu/doceo/document/E-9-2020-001897_EN.html - European Parliament [EP] (2020l). Parliamentary questions E-002295/2020. Question for
written answer to the Commission Rule 138 by Mathilde Androuët on 15 April 2020.
https://www.europarl.europa.eu/doceo/document/E-9-2020-002295_EN.html
- European Parliament [EP] (2020m). Parliamentary questions E-002499/2020. Question for written answer to the Commission Rule 138 by L270Gianna Gancia, Matteo Adinolfi, Angel Dzhambazki, Andrey Slabakov, Gilles Lebreton, Tom Vandendriessche, Aurelia Beigneux, Virginie Joron, Eugen Tomac, Milan Uhrík, Lars Patrick Berg, Joanna Kopcińska, Jadwiga Wiśniewska, Aldo Patriciello, Markus Buchheit, Annika Bruna, Maximilian Krah, Romana Jerković, Elżbieta Kruk, Jean-Paul Garraud on 24 April 2020.
https://www.europarl.europa.eu/doceo/document/E-9-2020-002499_EN.html
- European Parliament [EP] (2020n). Parliamentary questions E-002678/2020. Question for written answer to the Commission Rule 138 by Julie Lechanteux on 4 May 2020.
https://www.europarl.europa.eu/doceo/document/E-9-2020-002678_EN.html
- European Parliament [EP] (2020o). Parliamentary questions E-002717/2020. Question for written answer to the Commission Rule 138 by Henna Virkkunen on 5 May 2020.
https://www.europarl.europa.eu/doceo/document/E-9-2020-002717_EN.html
- European Parliament [EP] (2020p). Parliamentary questions E-002901/2020. Question for written answer to the Commission Rule 138 by Tomislav Sokol (PPE) on 12 May
2020.https://www.europarl.europa.eu/doceo/document/E-9-2020-002901_EN.html - European Parliament [EP] (2020q). P9_TA-PROV(2020)0205: The EU’s public health strategy
post-COVID-19 - European Parliament resolution of 10 July 2020 on the EU’s public health strategy post-COVID-19 (2020/2691(RSP))
https://www.europarl.europa.eu/doceo/document/TA-9-2020-0205_EN.html
- European Parliament & The Council of the European Union (2001). Directive 2001/83/EC of The European Parliament and of The Council of 6 November 2001 on the Community code relating to medicinal products for human use.
https://eur-lex.europa.eu/legal-content/en/ALL/?uri=CELEX:32001L0083